SCHEMBL4395300

SCHEMBL4395300

O=C(O)c1cc2cccnc2n1CCc1ccccc1

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CCR2 P41597 4/20 0.52
CYP1A2 P05177 2/20 0.47
KDM4E B2RXH2 2/20 0.47
MEN1 O00255 1/20 0.47
CYP3A4 P08684 1/20 0.47
CYP2D6 P10635 1/20 0.47
CYP2C19 P33261 1/20 0.47
KMT2A Q03164 1/20 0.47
ATM Q13315 1/20 0.47
CNR1 P21554 3/20 0.46
CNR2 P34972 3/20 0.46
POLB P06746 2/20 0.44
ALDH1A1 P00352 1/20 0.44
NPC1 O15118 1/20 0.44
RAB9A P51151 1/20 0.44
SMN1; SMN2 Q16637 1/20 0.44
LMNA P02545 1/20 0.43
HDAC1 Q13547 1/20 0.43
HDAC11 Q96DB2 1/20 0.43
HDAC8 Q9BY41 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3005616 0.86 CCR2 (0.62) CCR2CYP1A2KDM4EMEN1CYP3A4
SCHEMBL2814057 0.84 SMN1; SMN2 (0.54) CYP1A2KDM4EMEN1CYP3A4CYP2D6
SCHEMBL3757847 0.80 GPR35 (0.48) CCR2CYP1A2KDM4EMEN1CYP3A4
SCHEMBL2049484 0.80 CNR2 (0.46) CYP1A2KDM4EMEN1CYP3A4CYP2D6
SCHEMBL1422436 0.80 CCR2 (0.74) CCR2CYP1A2POLBALDH1A1MCL1
SCHEMBL298062 0.78 CCR2 (0.52) CCR2CYP1A2KDM4EMEN1CYP3A4
SCHEMBL2815078 0.77 ATM (0.62) CCR2CYP1A2KDM4EMEN1CYP3A4
SCHEMBL3009191 0.76 GPR35 (0.44) CCR2CYP1A2KDM4EMEN1CYP3A4
SCHEMBL2811264 0.76 ECE1 (0.53) CYP1A2KDM4EMEN1CYP3A4CYP2D6
SCHEMBL23269095 0.76 CYP1A2 (0.76) CYP1A2KDM4EMEN1CYP3A4CYP2D6

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-101247808-B N- (arylalkyl) -1H-pyrrolopyridine-2-carboxamide derivatives and their preparation SANOFI AVENTIS 2014-08-27 CN disclosed
EP-1912644-B1 N-(ARYLALKYL)-1H-PYRROLOPYRIDINE-2-CARBOXAMIDE DERIVATIVES, PREPARATION AND USE THEREOF SANOFI AVENTIS (FR) 2009-12-16 EP disclosed
CN-101247808-A N- (arylalkyl) -1H-pyrrolopyridine-2-carboxamide derivatives, their preparation and their therapeutic use SANOFI AVENTIS (FR) 2008-08-20 CN disclosed